Literature DB >> 1549571

Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases.

H Lomholt1, K Poulsen, D A Caugant, M Kilian.   

Abstract

Neisseria meningitidis is one of several important bacterial pathogens that secrete a specific protease capable of cleaving human immunoglobulin A1 (IgA1) in the hinge region. To obtain further information on this putative virulence factor, we examined the IgA1 protease and iga gene region of 133 isolates of N. meningitidis assigned to 88 multilocus enzyme genotypes and representing major epidemics and carrier strains from 19 countries. Of the two IgA1 cleavage specificities previously observed, isolates associated with epidemics of meningococcal disease showed exclusively type 1 IgA1 protease activity. Considerable heterogeneity of the N. meningitidis IgA1 protease was demonstrated at both the protein and gene levels. Thus, five different forms of IgA1 protease were detected with enzyme-neutralizing antibodies raised in rabbits. An antiserum raised against a single type 2 IgA1 protease inhibited the enzyme activity of all strains examined, a finding of potential significance for the possible application of IgA1 protease in a vaccine against meningococcal disease. Examination of the iga gene region with restriction endonucleases revealed a high degree of polymorphism among strains belonging to some multilocus enzyme genotypes. The different iga gene types did not correlate with cleavage type or inhibition of the IgA1 protease. Our findings indicate that horizontal genetic exchange occurs in vivo with considerably different frequency in different clones of meningococci.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549571      PMCID: PMC48608          DOI: 10.1073/pnas.89.6.2120

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  Variation and control of protein expression in Neisseria.

Authors:  T F Meyer; C P Gibbs; R Haas
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

2.  Molecular biology of Haemophilus influenzae IgA1 proteases.

Authors:  M Kilian; B Thomsen; T E Petersen; H Bleeg
Journal:  Mol Immunol       Date:  1983-09       Impact factor: 4.407

Review 3.  The IgA1 proteases of pathogenic bacteria.

Authors:  A G Plaut
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

4.  Cloning and sequencing of the immunoglobulin A1 protease gene (iga) of Haemophilus influenzae serotype b.

Authors:  K Poulsen; J Brandt; J P Hjorth; H C Thøgersen; M Kilian
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Homogeneity of protein serotype antigens in Neisseria meningitidis group A.

Authors:  J E Sippel; A Quan
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

6.  Genetic and biochemical analysis of gonococcal IgA1 protease: cloning in Escherichia coli and construction of mutants of gonococci that fail to produce the activity.

Authors:  J M Koomey; R E Gill; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Nucleotide sequence homology between the immunoglobulin A1 protease genes of Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae.

Authors:  J M Koomey; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Restriction site polymorphism in genes encoding type 2 but not type 1 gonococcal IgA1 proteases.

Authors:  M H Mulks; D A Simpson; R J Shoberg
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

9.  Mosaic-like organization of IgA protease genes in Neisseria gonorrhoeae generated by horizontal genetic exchange in vivo.

Authors:  R Halter; J Pohlner; T F Meyer
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

10.  IgA proteases of two distinct specificities are released by Neisseria meningitidis.

Authors:  M H Mulks; A G Plaut; H A Feldman; B Frangione
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

2.  Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.

Authors:  Gestur Vidarsson; Natasja Overbeeke; Annette M Stemerding; Germie van den Dobbelsteen; Peter van Ulsen; Peter van der Ley; Mogens Kilian; Jan G J van de Winkel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Evidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae.

Authors:  H Lomholt
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

4.  Relaxed cleavage specificity of an immunoglobulin A1 protease from Neisseria meningitidis.

Authors:  Srdjan Vitovski; Jon R Sayers
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

5.  Antigenic relationships among immunoglobulin A1 proteases from Haemophilus, Neisseria, and Streptococcus species.

Authors:  H Lomholt; M Kilian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period.

Authors:  N H Eriksen; F Espersen; V T Rosdahl; K Jensen
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

7.  Antigenic variation of immunoglobulin A1 proteases among sequential isolates of Haemophilus influenzae from healthy children and patients with chronic obstructive pulmonary disease.

Authors:  H Lomholt; L van Alphen; M Kilian
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Evolutionary genetics of the proline permease gene (putP) and the control region of the proline utilization operon in populations of Salmonella and Escherichia coli.

Authors:  K Nelson; R K Selander
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

Review 9.  Vaccines for bacterial sexually transmitted infections: a realistic goal?

Authors:  P F Sparling; C Elkins; P B Wyrick; M S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 10.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.